NEW YORK – Adding RNA-based genetic testing to DNA tests can clarify what variants of uncertain significance in hereditary cancer genes mean and change how patients' care is managed, according to a new analysis led by researchers at Ambry Genetics.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.
This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).